Market Cap 7.95B
Revenue (ttm) 507.44M
Net Income (ttm) -187.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -36.99%
Debt to Equity Ratio 0.00
Volume 122,407
Avg Vol 734,032
Day's Range N/A - N/A
Shares Out 58.73M
Stochastic %K 38%
Beta 0.94
Analysts Strong Sell
Price Target $151.08

Company Profile

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patient...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 367 9600
Fax: 949 367 9984
Address:
One Glaukos Way, Aliso Viejo, United States
Synaptric
Synaptric May. 13 at 1:31 PM
15 good-looking healthcare charts in this sad, narrow, semi/tech-only market. $XLV $CNC $GKOS $LNTH $JAZZ
0 · Reply
SuperGreenToday
SuperGreenToday May. 4 at 7:58 PM
$GKOS Share Price: $135.98 Contract Selected: Oct 16, 2026 $135 Calls Buy Zone: $15.39 – $19.01 Target Zone: $28.15 – $34.41 Potential Upside: 73% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Avocado_smash
Avocado_smash May. 1 at 1:01 AM
$GKOS Structure and Trend strength up>
0 · Reply
topstockalerts
topstockalerts Apr. 30 at 8:45 PM
$GKOS this strength feels real… not just a quick pop
0 · Reply
Doozio
Doozio Apr. 30 at 6:23 PM
$GKOS dips are a 🎁 this early ENTA 🐒🍌🧠⏰♾️
0 · Reply
PenkeInvesting
PenkeInvesting Apr. 30 at 6:05 PM
Fundamental analysis of $GKOS (GLAUKOS Corp) based on financial data and reported results. #GKOS #GLAUKOS
0 · Reply
STACKD0E
STACKD0E Apr. 30 at 3:24 PM
$GKOS 🫠
0 · Reply
Kingofstocks0001
Kingofstocks0001 Apr. 30 at 1:34 PM
$GKOS to mars!!!!!!!!!
0 · Reply
Kingofstocks0001
Kingofstocks0001 Apr. 30 at 1:32 PM
$GKOS how high will we go?!!!!
0 · Reply
Niddi
Niddi Apr. 30 at 12:57 PM
$GKOS Fly me to tbe moon…..
0 · Reply
Latest News on GKOS
Glaukos price target raised to $170 from $160 at Stifel

2026-04-30T16:01:03.000Z - 13 days ago

Glaukos price target raised to $170 from $160 at Stifel


Glaukos price target raised to $140 from $120 at JPMorgan

2026-04-30T15:49:51.000Z - 13 days ago

Glaukos price target raised to $140 from $120 at JPMorgan


Glaukos price target raised to $136 from $127 at Needham

2026-04-30T12:55:10.000Z - 13 days ago

Glaukos price target raised to $136 from $127 at Needham


Glaukos price target raised to $141 from $131 at BTIG

2026-04-30T12:38:00.000Z - 13 days ago

Glaukos price target raised to $141 from $131 at BTIG


Glaukos price target raised to $140 from $135 at Citi

2026-04-30T11:45:13.000Z - 13 days ago

Glaukos price target raised to $140 from $135 at Citi


Glaukos reports Q1 EPS (18c), consensus (28c)

2026-04-29T21:40:59.000Z - 13 days ago

Glaukos reports Q1 EPS (18c), consensus (28c)


Glaukos sees FY26 revenue $620M-$635M, consensus $614.4M

2026-04-29T21:40:03.000Z - 13 days ago

Glaukos sees FY26 revenue $620M-$635M, consensus $614.4M


Glaukos Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 13 days ago

Glaukos Earnings Call Transcript: Q1 2026


Glaukos Announces First Quarter 2026 Financial Results

Apr 29, 2026, 4:05 PM EDT - 13 days ago

Glaukos Announces First Quarter 2026 Financial Results


Glaukos Announces the Release of its 2025 Sustainability Report

Apr 16, 2026, 7:00 AM EDT - 27 days ago

Glaukos Announces the Release of its 2025 Sustainability Report


Glaukos receives permanent J-code for Epioxa

2026-04-15T20:15:44.000Z - 27 days ago

Glaukos receives permanent J-code for Epioxa


Glaukos Receives Permanent J-code for Epioxa™

Apr 15, 2026, 4:05 PM EDT - 27 days ago

Glaukos Receives Permanent J-code for Epioxa™


Glaukos price target raised to $135 from $125 at Citi

2026-04-07T11:01:34.000Z - 5 weeks ago

Glaukos price target raised to $135 from $125 at Citi


Glaukos announces commercial availability of Epioxa HD/Epioxa

2026-03-19T11:12:04.000Z - 7 weeks ago

Glaukos announces commercial availability of Epioxa HD/Epioxa


Glaukos management to meet with Piper Sandler

2026-03-12T20:13:14.000Z - 2 months ago

Glaukos management to meet with Piper Sandler


Glaukos price target raised to $127 from $125 at Needham

2026-02-18T12:20:55.000Z - 3 months ago

Glaukos price target raised to $127 from $125 at Needham


Glaukos price target raised to $135 from $122 at Wells Fargo

2026-02-18T11:31:03.000Z - 3 months ago

Glaukos price target raised to $135 from $122 at Wells Fargo


Glaukos Earnings Call Transcript: Q4 2025

Feb 17, 2026, 4:30 PM EST - 3 months ago

Glaukos Earnings Call Transcript: Q4 2025


Glaukos reports Q4 adjusted EPS (28c), consensus (30c)

2026-02-17T21:12:49.000Z - 3 months ago

Glaukos reports Q4 adjusted EPS (28c), consensus (30c)


Glaukos sees FY26 revenue $600M-$620M, consensus $613.35M

2026-02-17T21:12:32.000Z - 3 months ago

Glaukos sees FY26 revenue $600M-$620M, consensus $613.35M


Notable companies reporting after market close

2026-02-17T19:16:06.000Z - 3 months ago

Notable companies reporting after market close

CDNS PANW TOL


Glaukos Transcript: Stephens Annual Investment Conference

Nov 18, 2025, 11:00 AM EST - 6 months ago

Glaukos Transcript: Stephens Annual Investment Conference


Glaukos Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 1:20 PM EST - 6 months ago

Glaukos Transcript: Stifel 2025 Healthcare Conference


Glaukos Transcript: UBS Global Healthcare Conference 2025

Nov 11, 2025, 10:15 AM EST - 6 months ago

Glaukos Transcript: UBS Global Healthcare Conference 2025


Glaukos Earnings Call Transcript: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 6 months ago

Glaukos Earnings Call Transcript: Q3 2025


Glaukos Announces Third Quarter 2025 Financial Results

Oct 29, 2025, 4:05 PM EDT - 6 months ago

Glaukos Announces Third Quarter 2025 Financial Results


US FDA approves Glaukos' new eye therapy

Oct 20, 2025, 7:10 AM EDT - 7 months ago

US FDA approves Glaukos' new eye therapy


Glaukos Announces FDA Approval of Epioxa™

Oct 20, 2025, 7:00 AM EDT - 7 months ago

Glaukos Announces FDA Approval of Epioxa™


Glaukos Earnings Call Transcript: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 10 months ago

Glaukos Earnings Call Transcript: Q2 2025


Glaukos Announces Second Quarter 2025 Financial Results

Jul 30, 2025, 4:05 PM EDT - 10 months ago

Glaukos Announces Second Quarter 2025 Financial Results


Glaukos Transcript: Stifel 2025 Virtual Ophthalmology Forum

May 27, 2025, 12:30 PM EDT - 1 year ago

Glaukos Transcript: Stifel 2025 Virtual Ophthalmology Forum


Glaukos Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Glaukos Earnings Call Transcript: Q1 2025


Glaukos Announces First Quarter 2025 Financial Results

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Glaukos Announces First Quarter 2025 Financial Results


Glaukos Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Glaukos Earnings Call Transcript: Q4 2024


Glaukos Transcript: Citi's 2024 Global Healthcare Conference

Dec 5, 2024, 9:30 AM EST - 1 year ago

Glaukos Transcript: Citi's 2024 Global Healthcare Conference


Glaukos Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 12:40 PM EST - 1 year ago

Glaukos Transcript: Stifel 2024 Healthcare Conference


Glaukos Earnings Call Transcript: Q3 2024

Nov 4, 2024, 4:30 PM EST - 1 year ago

Glaukos Earnings Call Transcript: Q3 2024


Glaukos Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

Glaukos Announces Third Quarter 2024 Financial Results


Glaukos Transcript: 2024 Wells Fargo Healthcare Conference

Sep 4, 2024, 12:45 PM EDT - 1 year ago

Glaukos Transcript: 2024 Wells Fargo Healthcare Conference


Glaukos Earnings Call Transcript: Q2 2024

Jul 31, 2024, 4:30 PM EDT - 1 year ago

Glaukos Earnings Call Transcript: Q2 2024


Glaukos Announces Second Quarter 2024 Financial Results

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Glaukos Announces Second Quarter 2024 Financial Results


Glaukos Transcript: 2024 Truist Securities MedTech Conference

Jun 18, 2024, 12:45 PM EDT - 2 years ago

Glaukos Transcript: 2024 Truist Securities MedTech Conference


Glaukos Transcript: AGM 2024

May 30, 2024, 12:00 PM EDT - 2 years ago

Glaukos Transcript: AGM 2024


Glaukos Earnings Call Transcript: Q1 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Glaukos Earnings Call Transcript: Q1 2024


Glaukos Announces First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 2 years ago

Glaukos Announces First Quarter 2024 Financial Results


Glaukos Announces the Release of its 2023 Sustainability Report

Apr 16, 2024, 4:05 PM EDT - 2 years ago

Glaukos Announces the Release of its 2023 Sustainability Report


Glaukos Earnings Call Transcript: Q4 2023

Feb 21, 2024, 4:30 PM EST - 2 years ago

Glaukos Earnings Call Transcript: Q4 2023


Synaptric
Synaptric May. 13 at 1:31 PM
15 good-looking healthcare charts in this sad, narrow, semi/tech-only market. $XLV $CNC $GKOS $LNTH $JAZZ
0 · Reply
SuperGreenToday
SuperGreenToday May. 4 at 7:58 PM
$GKOS Share Price: $135.98 Contract Selected: Oct 16, 2026 $135 Calls Buy Zone: $15.39 – $19.01 Target Zone: $28.15 – $34.41 Potential Upside: 73% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Avocado_smash
Avocado_smash May. 1 at 1:01 AM
$GKOS Structure and Trend strength up>
0 · Reply
topstockalerts
topstockalerts Apr. 30 at 8:45 PM
$GKOS this strength feels real… not just a quick pop
0 · Reply
Doozio
Doozio Apr. 30 at 6:23 PM
$GKOS dips are a 🎁 this early ENTA 🐒🍌🧠⏰♾️
0 · Reply
PenkeInvesting
PenkeInvesting Apr. 30 at 6:05 PM
Fundamental analysis of $GKOS (GLAUKOS Corp) based on financial data and reported results. #GKOS #GLAUKOS
0 · Reply
STACKD0E
STACKD0E Apr. 30 at 3:24 PM
$GKOS 🫠
0 · Reply
Kingofstocks0001
Kingofstocks0001 Apr. 30 at 1:34 PM
$GKOS to mars!!!!!!!!!
0 · Reply
Kingofstocks0001
Kingofstocks0001 Apr. 30 at 1:32 PM
$GKOS how high will we go?!!!!
0 · Reply
Niddi
Niddi Apr. 30 at 12:57 PM
$GKOS Fly me to tbe moon…..
0 · Reply
GetVector
GetVector Apr. 30 at 12:55 PM
Vector Intelligence (VI) is an algorithm designed to predict potential outsized intraday moves. VI will select up to 4 stocks per day. Today's VI stocks: $BAND, $GKOS, $OPCH, $VIAV.
0 · Reply
Kingofstocks0001
Kingofstocks0001 Apr. 29 at 11:50 PM
$GKOS wow!!!!!!!!
1 · Reply
Niddi
Niddi Apr. 29 at 8:32 PM
$GKOS We should see a revised target of $150 by analysts. Just my opinion.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 29 at 8:26 PM
$GKOS Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.34 down -6.25% YoY • Reported revenue of $150.57M up 41.16% YoY • Glaukos raised its 2026 net sales guidance to a range of $620 million to $635 million, up from the previous range of $600 million to $620 million.
0 · Reply
Niddi
Niddi Apr. 29 at 8:22 PM
0 · Reply
Niddi
Niddi Apr. 29 at 8:16 PM
$GKOS Boom!
0 · Reply
Niddi
Niddi Apr. 28 at 2:46 PM
$GKOS Good time to add. Would explode after earnings call imho.
0 · Reply
Niddi
Niddi Apr. 22 at 5:37 PM
$GKOS Manipulation and accumulation.
0 · Reply
Doozio
Doozio Apr. 20 at 3:02 PM
$GKOS cmon bruh. It was always ONTO 🐒🍌🧠⏰♾️
0 · Reply
IN0V8
IN0V8 Apr. 8 at 1:51 PM
$GKOS Buy Citigroup raises target price to $135 from $125
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 31 at 12:31 PM
$GKOS Share Price: $105.05 Contract Selected: Oct 16, 2026 $105 Calls Buy Zone: $13.23 – $16.35 Target Zone: $24.64 – $30.12 Potential Upside: 76% ROI Time to Expiration: 198 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 26 at 8:06 PM
$GKOS RSI: 50.28, MACD: -2.1775 Vol: 7.17, MA20: 106.94, MA50: 113.03 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply